Mechanisms of viral mutation.
Sanjuán R, Domingo-Calap P.
Cell Mol Life Sci. 2016 Dec;73(23):4433-4448. doi: 10.1007/s00018-016-2299-6. Epub 2016 Jul 8.
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS.
Nat Biotechnol. 2016 Feb;34(2):155-63. doi: 10.1038/nbt.3391. Epub 2015 Nov 30.
Genomic instability--an evolving hallmark of cancer.
Negrini S, Gorgoulis VG, Halazonetis TD.
Nat Rev Mol Cell Biol. 2010 Mar;11(3):220-8. doi: 10.1038/nrm2858.
Splicing mutations in human genetic disorders: examples, detection, and confirmation.
Anna A, Monika G.
J Appl Genet. 2018 Aug;59(3):253-268. doi: 10.1007/s13353-018-0444-7. Epub 2018 Apr 21.
Mutation bias and adaptation in bacteria.
Horton JS, Taylor TB.
Microbiology (Reading). 2023 Nov;169(11):001404. doi: 10.1099/mic.0.001404.
Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations.
Pros E, Gómez C, Martín T, Fábregas P, Serra E, Lázaro C.
Hum Mutat. 2008 Sep;29(9):E173-93. doi: 10.1002/humu.20826.
Mutator transposons.
Lisch D.
Trends Plant Sci. 2002 Nov;7(11):498-504. doi: 10.1016/s1360-1385(02)02347-6.
Evolutionary Landscapes of Host-Virus Arms Races.
Tenthorey JL, Emerman M, Malik HS.
Annu Rev Immunol. 2022 Apr 26;40:271-294. doi: 10.1146/annurev-immunol-072621-084422. Epub 2022 Jan 26.
APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential.
Butler K, Banday AR.
J Hematol Oncol. 2023 Mar 28;16(1):31. doi: 10.1186/s13045-023-01425-5.
Pediatric cancer genetics.
Dean SJ, Farmer M.
Curr Opin Pediatr. 2017 Dec;29(6):629-633. doi: 10.1097/MOP.0000000000000543.
